language_icon
EN
HI

Healthcare Global Enterprises Share price

HCG

656

0.05 (0.01%)
NSE
BSE
Last updated on 26 May, 2026 | 15:29 IST
Today's High

658.95

Today's Low

648.35

52 Week Low

513.30

52 Week High

796.68

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Healthcare Global Enterprises Chart

Healthcare Global Enterprises Share Key Metrics

Volume
2.05 L
Market Cap
9793.48 CR
LTQ@LTP
1@656.00
ATP
655.73
Var Margin
16.42 %
Circuit Range
524.8-787.1
Delivery %
67.55 %
Value
13.43 CR
ASM/GSM
No
Market Lot
1

Summary

Healthcare Global Enterprises share price is ₹656 as of 27 May, 2026. The stock Healthcare Global Enterprises intraday movement has stayed between ₹648.35 and ₹658.95, while on a 52-week basis,Healthcare Global Enterprises price 52 week high is ₹796.68 & its 52 week low is ₹513.30.
In terms of trading activity, Healthcare Global Enterprises has recorded a volume of 204808 shares, The Healthcare Global Enterprises has a market cap of ₹149302204 CR. The stock’s Average Traded Price (ATP) stands at ₹655.73, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹656.00.
Healthcare Global Enterprises operates within a circuit range of ₹524.80 – ₹787.10, with a Value of ₹13.43 CR. The Delivery Percentage for the day is 67.55%. Additionally, Healthcare Global Enterprises currently falls under the No framework, and trades with a market lot size of 1.

Healthcare Global Enterprises Fundamentals

View More
P/E Ratio

712.55

P/B Ratio

7.36

Div. Yield

0

Sector P/E

57.5

Sector P/B

-15.76

Sec. Div. Yield

0.19

Healthcare Global Enterprises Resistance and Support

Pivot 654.9

Resistance

First Resistance

664.8

Second Resistance

673.65

Third Resistance

683.55

Support

First Support

646.05

Second Support

636.15

Third Support

627.3

Healthcare Global Enterprises Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

71.23%

Mutual Fund

10.04%

Insurance

0.22%

Foreign Institutional Investors

2.77%

Domestic Institutional Investors

2.68%

Retail

13.06%

Others

0%

Total Promoters
MAR '24
71.28%
JUN '24
71.25%
SEP '24
71.23%
DEC '24
71.23%

Healthcare Global Enterprises Corporate Actions

DateAgenda
2026-05-19Audited Results
2026-02-17Rights issue of Equity Shares
2026-02-05Quarterly Results
2025-11-12Quarterly Results
2025-08-01Quarterly Results
2025-05-24Audited Results
2025-02-14Quarterly Results & Others
2025-02-13Quarterly Results & Others

Healthcare Global Enterprises News

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Healthcare Global Enterprises held an earnings call on May 20, 2026, detailing Q4 & FY26 performance. The company reported FY26 revenue growth of 15% and adjusted EBITDA growth of 19%, while also announcing the strategic sale of its Milann fertility business.
May 26 2026 15:41:39

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

HealthCare Global Enterprises made the audio recording of its Earnings Call for Q4 FY26 and full year FY26 financial results available. This provides investors access to management's discussion and insights on the company's performance.
May 20 2026 17:50:49

Healthcare Global Enterprises Limited

Healthcare Global Enterprises appointed Mr. Sanjeev Kumar as its Chief Financial Officer, effective May 25, 2026. He brings over 30 years of experience, including roles as Group CFO at InterGlobe and Medanta, and was instrumental in Medanta's IPO.
May 19 2026 23:57:27

Healthcare Global Enterprises Limited

HealthCare Global Enterprises Limited divested its 100% equity shareholding in BACC Health Care Private Limited for INR 37.64 crore. This transaction allows the company to exit a non-core business segment, with completion expected within 4-5 weeks.
May 19 2026 23:48:50

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Healthcare Global reported strong FY26 consolidated results. Revenue grew 15% YoY to Rs.2,545.4 cr, and adjusted net profit increased 25% YoY to Rs.55.7 cr. Q4 saw a 363% surge in adjusted net profit to Rs.34.1 cr, reflecting continued operational improvement and margin expansion.
May 19 2026 23:29:58

HealthCare Global Enterprises Ltd - 539787 - Re-Appointment Of Internal Auditor Of The Company

Healthcare Global's Board of Directors approved several key appointments/re-appointments. This includes a new Chief Financial Officer, a new AVP-Investor Relations, and the re-appointment of an Independent Director and Internal Auditor.
May 19 2026 23:20:31

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Change in Directorate

Healthcare Global Enterprises appointed Mr. Sanjeev Kumar as Chief Financial Officer and Key Managerial Personnel, effective May 25, 2026. Mr. Kumar brings over 30 years of experience in finance, including key roles at Bharti Airtel and Medanta.
May 19 2026 23:12:13

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment

Healthcare Global Enterprises divested its entire equity shareholding in BACC Health Care Private Limited for Rs.37.64 crore. This strategic move aims to enhance operational focus on core oncology and high-growth areas.
May 19 2026 23:05:23

HealthCare Global Enterprises Ltd - 539787 - Intimation Regarding Launch Of New Comprehensive Cancer Hospital Of The Company In Hebbal, North Bangalore.

Healthcare Global Enterprises launched a new 132-bed comprehensive cancer hospital in Hebbal, North Bengaluru today. This Rs.129 crore investment expands advanced oncology care and features Karnataka's first Elekta Unity MR-Linac.
May 19 2026 13:28:30

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Healthcare Global Enterprises launched a new 132-bed comprehensive cancer hospital in Hebbal, North Bengaluru. This facility introduces Karnataka's first Elekta Unity MR-Linac, significantly strengthening advanced oncology access in the region.
May 19 2026 13:08:20
Read More

Healthcare Global Enterprises Management

NamePosition
Sunu ManuelCompany Secretary & Compliance Officer
B S Ajai KumarChairman
View More

Healthcare Global Enterprises FAQs

The Buying Price of Healthcare Global Enterprises share is 656 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Healthcare Global Enterprises stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Healthcare Global Enterprises, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Healthcare Global Enterprises shares is 712.55. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Healthcare Global Enterprises shares is 7.36. Useful to assess the stock's value relative to its book value.

To assess Healthcare Global Enterprises’s valuation compare Sector P/E, P/B which are 57.5 & -15.76 with sector averages, along with growth rates and financial metrics.

The Market Cap of Healthcare Global Enterprises is 9793.48 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Healthcare Global Enterprises share price is 796.68 & 513.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Healthcare Global Enterprises belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost